10h
FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions
The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.
13hon MSN
Nasal spray sold nationwide recalled due to mold, ‘life-threatening' infections possible, FDA says
The voluntary recall of ReBoost Nasal Spray was issued Wednesday by MediNatura New Mexico, according to an announcement from ...
The FDA has approved Linzess (linaclotide) for treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback